Glipizide Tablet, Film Coated, Extended Release
Product Images NDC 51655-966

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 51655-966). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-966-52 (51655 966 52 Rev A 06 23)

Label for GlipiZIDE Extended-Release Tablets, 10 mg, oral film-coated tablets. The package contains 30 tablets. It is labeled as prescription only and advises to see the package insert for dosage information. Storage instructions specify 20° to 25°C (68° to 77°F). Manufactured and repackaged by Northwind Pharmaceuticals.*

FDA Label Image

Structural Formula (Structural Formula)

Chemical structure diagram of Glipizide, the active ingredient in the product. The image shows the molecular configuration including various rings, functional groups, and bonds characteristic of Glipizide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.